BeOne Medicines - EBITDA 2014-2025 | ONC

BeOne Medicines - annual and quarterly EBITDA history from 2014 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

BeOne Medicines - EBITDA for the quarter ending September 30, 2025 was $0.200B, a 509.2% decline year-over-year.
BeOne Medicines - EBITDA for the twelve months ending September 30, 2025 was $0.339B, a 146.56% decline year-over-year.
BeOne Medicines - 2024 annual EBITDA was $-0.396B, a 64.61% decline from 2023.
BeOne Medicines - 2023 annual EBITDA was $-1.12B, a 35.01% decline from 2022.
BeOne Medicines - 2022 annual EBITDA was $-1.723B, a 23.78% increase from 2021.

BeOne Medicines - Annual EBITDA (Millions of US $)
2024	$-396
2023	$-1,120
2022	$-1,723
2021	$-1,392
2020	$-1,626
2019	$-941
2018	$-695
2017	$-94
2016	$-115
2015	$-55
2014	$-14
2013	$-4

BeOne Medicines - Quarterly EBITDA (Millions of US $)
2025-09-30	$200
2025-06-30	$123
2025-03-31	$44
2024-12-31	$-29
2024-09-30	$-49
2024-06-30	$-82
2024-03-31	$-236
2023-12-31	$-360
2023-09-30	$-112
2023-06-30	$-296
2023-03-31	$-351
2022-12-31	$-451
2022-09-30	$-422
2022-06-30	$-424
2022-03-31	$-427
2021-12-31	$-559
2021-09-30	$-450
2021-06-30	$-463
2021-03-31	$80
2020-12-31	$-477
2020-09-30	$-432
2020-06-30	$-351
2020-03-31	$-366
2019-12-31	$-381
2019-09-30	$-308
2019-06-30	$-82
2019-03-31	$-170
2018-12-31	$-277
2018-09-30	$-149
2018-06-30	$-161
2018-03-31	$-109
2017-12-31	$-102
2017-09-30	$116
2017-06-30	$-57
2017-03-31	$-51
2016-12-31	$-37
2016-09-30	$-34
2016-06-30	$-24
2016-03-31	$-20
2015-12-31	$-26
2015-06-30	$-6
2015-03-31	$-9
2014-12-31
2013-12-31

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$36.658B	$3.810B
BeOne Medicines is an oncology company which involved in discovering and developing treatments to cancer patients. BeOne Medicines, formerly known as BeiGene Ltd., is based in SAN CARLOS, Calif.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$84.909B	32.25
Zoetis (ZTS)	United States	$54.311B	19.44
Takeda Pharmaceutical (TAK)	Japan	$51.389B	10.49
Daiichi Sankyo, - (DSNKY)	Japan	$38.891B	19.37
Sandoz Group AG (SDZNY)	Switzerland	$33.832B	0.00
United Therapeutics (UTHR)	United States	$20.154B	17.74
Merck (MKKGY)	Germany	$19.005B	11.72
Shionogi (SGIOY)	Japan	$15.636B	14.36
Neurocrine Biosciences (NBIX)	United States	$13.414B	32.19
IPSEN (IPSEY)	France	$12.891B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.558B	0.00
Summit Therapeutics (SMMT)	United States	$12.385B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.468B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.120B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.967B	21.19
Grifols, S.A (GRFS)	Spain	$5.940B	0.00
Stevanato Group S.p.A (STVN)	Italy	$5.784B	32.37
Crinetics Pharmaceuticals (CRNX)	United States	$5.285B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.190B	19.90
Indivior (INDV)	United States	$4.119B	16.81
Corcept Therapeutics (CORT)	United States	$3.712B	40.10
NewAmsterdam Pharma (NAMS)	Netherlands	$3.675B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.081B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.874B	9.17
Hypermarcas (HYPMY)	Brazil	$2.755B	18.91
Ocular Therapeutix (OCUL)	United States	$2.439B	0.00
Dyne Therapeutics (DYN)	United States	$2.368B	0.00
Soleno Therapeutics (SLNO)	United States	$2.349B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.950B	23.11
Ardelyx (ARDX)	United States	$1.885B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.818B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.793B	34.54
Harrow (HROW)	United States	$1.767B	108.46
Oruka Therapeutics (ORKA)	United States	$1.609B	0.00
Enliven Therapeutics (ELVN)	United States	$1.605B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.508B	7.46
BioCryst Pharmaceuticals (BCRX)	United States	$1.406B	83.38
Relay Therapeutics (RLAY)	United States	$1.284B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.263B	0.00
Savara (SVRA)	United States	$1.215B	0.00
Evotec AG (EVO)	Germany	$1.204B	0.00
Theravance Biopharma (TBPH)	United States	$1.035B	43.45
ARS Pharmaceuticals (SPRY)	United States	$1.033B	0.00
Cronos Group (CRON)	Canada	$0.973B	0.00
Aktis Oncology (AKTS)	United States	$0.951B	0.00
Xencor (XNCR)	United States	$0.903B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.774B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.745B	17.61
Nektar Therapeutics (NKTR)	United States	$0.737B	0.00
Esperion Therapeutics (ESPR)	United States	$0.691B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.660B	5.89
ProKidney (PROK)	United States	$0.644B	0.00
Bioventus (BVS)	United States	$0.638B	13.07
Lexeo Therapeutics (LXEO)	United States	$0.530B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.508B	0.00
Lyell Immunopharma (LYEL)	United States	$0.508B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.505B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.480B	0.00
Organogenesis (ORGO)	United States	$0.471B	0.00
Siga Technologies (SIGA)	United States	$0.468B	6.41
Altimmune (ALT)	United States	$0.441B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.435B	0.00
Aquestive Therapeutics (AQST)	United States	$0.425B	0.00
Nature's Sunshine Products (NATR)	United States	$0.418B	24.91
USANA Health Sciences (USNA)	United States	$0.402B	11.21
Cybin (HELP)	Canada	$0.383B	0.00
Akebia Therapeutics (AKBA)	United States	$0.356B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.292B	0.00
Protara Therapeutics (TARA)	United States	$0.289B	0.00
Relmada Therapeutics (RLMD)	United States	$0.289B	0.00
Profound Medical (PROF)	Canada	$0.286B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.286B	0.00
Avalo Therapeutics (AVTX)	United States	$0.274B	0.00
OmniAb (OABI)	United States	$0.274B	0.00
Larimar Therapeutics (LRMR)	United States	$0.265B	0.00
Fractyl Health (GUTS)	United States	$0.262B	0.00
Heron Therapeutics (HRTX)	United States	$0.260B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.246B	0.00
Journey Medical (DERM)	United States	$0.237B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.233B	0.00
MediWound (MDWD)	Israel	$0.218B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.207B	0.00
Galectin Therapeutics (GALT)	United States	$0.193B	0.00
Minerva Neurosciences (NERV)	United States	$0.189B	0.00
AleAnna (ANNA)	United States	$0.183B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.168B	0.00
VAXART, INC (VXRT)	United States	$0.166B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Surrozen (SRZN)	United States	$0.154B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.151B	0.00
Context Therapeutics (CNTX)	United States	$0.141B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.141B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.127B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.124B	0.00
Incannex Healthcare (IXHL)	Australia	$0.124B	0.00
Prelude Therapeutics (PRLD)	United States	$0.116B	0.00
Avita Medical (RCEL)	United States	$0.115B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.109B	0.00
Pyxis Oncology (PYXS)	United States	$0.103B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.101B	0.00
Vivani Medical (VANI)	United States	$0.099B	0.00
Champions Oncology (CSBR)	United States	$0.097B	41.18
Cassava Sciences (SAVA)	United States	$0.096B	0.00
Korro Bio (KRRO)	United States	$0.081B	0.00
Gain Therapeutics (GANX)	United States	$0.077B	0.00
Assertio Holdings (ASRT)	United States	$0.075B	0.00
PolyPid (PYPD)	Israel	$0.071B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.071B	59.00
Dominari Holdings (DOMH)	United States	$0.067B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.065B	0.00
Arch Biopartners (ACHFF)	Canada	$0.064B	0.00
Rafael Holdings (RFL)	United States	$0.063B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.062B	0.00
Metagenomi (MGX)	United States	$0.060B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.057B	0.00
Nutriband (NTRB)	United States	$0.056B	0.00
Lipocine (LPCN)	United States	$0.055B	0.00
ElectroCore (ECOR)	United States	$0.055B	0.00
Lite Strategy (LITS)	United States	$0.048B	0.00
Talphera (TLPH)	United States	$0.046B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
Plus Therapeutics (PSTV)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.039B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.035B	0.00
Wellgistics Health (WGRX)	United States	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.031B	0.00
Natural Alternatives (NAII)	United States	$0.030B	0.00
TherapeuticsMD (TXMD)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
Klotho Neurosciences (KLTO)	United States	$0.023B	0.00
Traws Pharma (TRAW)	United States	$0.021B	0.03
Scienture Holdings (SCNX)	United States	$0.020B	0.00
Liminatus Pharma (LIMN)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Inotiv (NOTV)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.017B	0.00
Vyome Holdings (HIND)	United States	$0.016B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00